EMA Guidance on Trial Mgmt during COVID-19
Health Care, Pharma Industry, Strategic Planning
The impact of COVID-19 on ongoing trials, on opening a new trial site in an existing trial, ongoing recruitment and continued involvement of participants in the trial, or on starting of new trials needs to be considered. Read this EMA Guidance to learn more about managing your clinical trials during this pandemic.
Related Education Resources.
All ResourcesGCSG Presentation Tips from Steve Jacobs
Topics: Communication, Personal Development
Conference Training
Members
Environmental Sustainability & the Supply of Medicines for Use in Clinical Trials
Topic: Supply Chain
White Paper
Free
Covid-19 Supply Chain: Managing Risk & Disruption
Topics: Conference, COVID-19, Supply Chain
Executive Summary
Members
